Literature DB >> 33717489

Reconsidering LINE-1's role in cancer: does LINE-1 function as a reporter detecting early cancer-associated epigenetic signatures?

Maxfield M G Kelsey1.   

Abstract

Long interspersed nuclear element-1 (LINE-1 or L1) is the only autonomously active retrotransposon in humans. While L1 has been implicated in several pathologies and the aging process, I present a model which challenges an understanding of L1 as predominantly antagonistic to human health. I hypothesize that L1 serves as a reporter in an early cancer alert system: a tripwire strung throughout the genome poised to trigger p53 and a type I interferon (IFN-1) response when the epigenetic landscape portends cancer. Cell proliferation and a shift to aerobic glycolysis cause dramatic changes in the epigenome which are permissive to L1's escape from suppression. L1 has several properties which make it particularly apt to fulfill this hypothesized sentinel function. Being present in many copies spread throughout the genome allows it to monitor many regions for epigenetic instability and renders it robust to deactivation by mutation. This proposed cancer alert system would alter the cancer cell fitness landscape discouraging the use of growth-favoring aerobic glycolysis by threatening the activation of tumor-suppressive mechanisms. It also imposes costs on a strategy of non-specific global transcriptional derepression aimed at activating oncogenes. Erroneous activations of this system are predicted to increase the rate of aging, suggesting this represents a case of antagonistic pleiotropy trading prolonged youth for cancer prevention. More research is needed to assess this model. Lay summary: During carcinogenesis the epigenome is remodeled by the Warburg effect and cellular proliferation. These processes globally relax chromatin. This epigenetic environment is permissive to the retrotransposon long interspersed nuclear element-1's (LINE-1 or L1) escape from suppression. I hypothesize and present evidence for the notion that L1 has been co-opted to serve as a reporter in an early cancer alert system, poised to trigger tumor suppressive mechanisms when the epigenetic landscape portends cancer. This hypothesis describes a potentially major means by which transformation is thwarted early on.
© The Author(s) 2021. Published by Oxford University Press on behalf of the Foundation for Evolution, Medicine, and Public Health.

Entities:  

Keywords:  LINE-1; cancer; epigenetics; metabolism

Year:  2021        PMID: 33717489      PMCID: PMC7937435          DOI: 10.1093/emph/eoab004

Source DB:  PubMed          Journal:  Evol Med Public Health        ISSN: 2050-6201


  58 in total

1.  Hot L1s account for the bulk of retrotransposition in the human population.

Authors:  Brook Brouha; Joshua Schustak; Richard M Badge; Sheila Lutz-Prigge; Alexander H Farley; John V Moran; Haig H Kazazian
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-07       Impact factor: 11.205

2.  A universal classification of eukaryotic transposable elements implemented in Repbase.

Authors:  Vladimir V Kapitonov; Jerzy Jurka
Journal:  Nat Rev Genet       Date:  2008-05       Impact factor: 53.242

3.  Fitness cost of LINE-1 (L1) activity in humans.

Authors:  Stephane Boissinot; Jerel Davis; Ali Entezam; Dimitri Petrov; Anthony V Furano
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-09       Impact factor: 11.205

Review 4.  Cancer genetics and epigenetics: two sides of the same coin?

Authors:  Jueng Soo You; Peter A Jones
Journal:  Cancer Cell       Date:  2012-07-10       Impact factor: 31.743

Review 5.  Epigenetic Determinants of Cancer.

Authors:  Stephen B Baylin; Peter A Jones
Journal:  Cold Spring Harb Perspect Biol       Date:  2016-09-01       Impact factor: 10.005

6.  A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity.

Authors:  Michelle Percharde; Chih-Jen Lin; Yafei Yin; Juan Guan; Gabriel A Peixoto; Aydan Bulut-Karslioglu; Steffen Biechele; Bo Huang; Xiaohua Shen; Miguel Ramalho-Santos
Journal:  Cell       Date:  2018-06-21       Impact factor: 41.582

7.  Retrotransposition-Competent Human LINE-1 Induces Apoptosis in Cancer Cells With Intact p53.

Authors:  Abdelali Haoudi; O John Semmes; James M Mason; Ronald E Cannon
Journal:  J Biomed Biotechnol       Date:  2004

8.  The effects of the DNA methyltranfserases inhibitor 5-Azacitidine on ageing, oxidative stress and DNA methylation of adipose derived stem cells.

Authors:  Katarzyna Kornicka; Krzysztof Marycz; Monika Marędziak; Krzysztof A Tomaszewski; Jakub Nicpoń
Journal:  J Cell Mol Med       Date:  2016-12-20       Impact factor: 5.310

9.  Role of p53 in Cell Death and Human Cancers.

Authors:  Toshinori Ozaki; Akira Nakagawara
Journal:  Cancers (Basel)       Date:  2011-03-03       Impact factor: 6.639

Review 10.  Plasticity of Type I Interferon-Mediated Responses in Cancer Therapy: From Anti-tumor Immunity to Resistance.

Authors:  Megha Budhwani; Roberta Mazzieri; Riccardo Dolcetti
Journal:  Front Oncol       Date:  2018-08-21       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.